Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2009

01.01.2009 | Clinical study - patient study

Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma

verfasst von: Stephan Ulmer, Carsten Liess, Santosh Kesari, Nadine Otto, Torsten Straube, Olav Jansen

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction We investigated the effect of increased tumor perfusion using dynamic susceptibility-contrast magnetic resonance imaging (DSC-MRI) in glioblastoma (GBM) patients on the surrounding ipsilateral brain tissue with respect to perfusion of the normal, unaffected contralateral brain and of the tumor. Material and methods DSC-MRI was performed in 11 patients with glioblastoma using a multislice T2*-weighed EPI sequence (TR/TE = 2,000/62 ms; FOV 240 mm; matrix 128 × 128; slice thickness 6 mm) on a standard clinical 1.5 Tesla scanner during intravenous injection of 40 cc Gadolinium-DTPA at a flow rate of 5 cc/s. Maps for relative regional cerebral blood volume (rCBV) and relative regional cerebral blood flow (rCBF) were created and relative values analyzed in relation to the arterial input. Results Relative CBV and CBF were significantly higher in gray matter than in the respective white matter (paired t-test; P < 0.001) with a high correlation for both perfusion parameters between the gray and the white matter in both ipsilateral and contralateral brain (P < 0.001). The highest values for rCBV and rCBF were found in solid tumor tissue with a significant positive correlation between tumor and the adjacent gray matter (for both rCBV and rCBF; P < 0.001). Conclusion In GBM patients there is increased metabolism and thus increased rCBV and rCBF within the tumor. This increased perfusion of the tumor is not at the expense of perfusion of the ipsilateral normal brain parenchyma and in fact, the rCBV and rCBF values are linked to tumor-induced changes in rCBV and rCBF.
Literatur
2.
Zurück zum Zitat Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225 (Discussion 226–219)PubMed Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225 (Discussion 226–219)PubMed
5.
Zurück zum Zitat Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848. doi:10.1038/359845a0 PubMedCrossRef Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848. doi:10.​1038/​359845a0 PubMedCrossRef
6.
Zurück zum Zitat Zama A, Tamura M, Inoue HK (1991) Three-dimensional observations on microvascular growth in rat glioma using a vascular casting method. J Cancer Res Clin Oncol 117:396–402. doi:10.1007/BF01612757 PubMedCrossRef Zama A, Tamura M, Inoue HK (1991) Three-dimensional observations on microvascular growth in rat glioma using a vascular casting method. J Cancer Res Clin Oncol 117:396–402. doi:10.​1007/​BF01612757 PubMedCrossRef
9.
Zurück zum Zitat Earnest F 4th, Kelly PJ, Scheithauer BW et al (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827 Earnest F 4th, Kelly PJ, Scheithauer BW et al (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827
10.
Zurück zum Zitat Conturo TE, Akbudak E, Kotys MS et al (2005) Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J Magn Reson Imaging 22:697–703. doi:10.1002/jmri.20457 PubMedCrossRef Conturo TE, Akbudak E, Kotys MS et al (2005) Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J Magn Reson Imaging 22:697–703. doi:10.​1002/​jmri.​20457 PubMedCrossRef
12.
Zurück zum Zitat Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178:711–716PubMed Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178:711–716PubMed
13.
Zurück zum Zitat Sorensen AG, Copen WA, Ostergaard L et al (1999) Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210:519–527PubMed Sorensen AG, Copen WA, Ostergaard L et al (1999) Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210:519–527PubMed
14.
Zurück zum Zitat Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859–867PubMed Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859–867PubMed
16.
Zurück zum Zitat Knopp EA, Cha S, Johnson G et al (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791–798PubMed Knopp EA, Cha S, Johnson G et al (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791–798PubMed
17.
18.
Zurück zum Zitat Lev ML, Ozsunar Y, Henson JW et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared to conventional contrast enhanced MRI: confounding effect of elevated relative cerebral blood volume of oligodendrogliomas. AJNR Am J Neuroradiol 25:214–221PubMed Lev ML, Ozsunar Y, Henson JW et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared to conventional contrast enhanced MRI: confounding effect of elevated relative cerebral blood volume of oligodendrogliomas. AJNR Am J Neuroradiol 25:214–221PubMed
19.
Zurück zum Zitat Cha S, Knopp EA, Johnson G et al (2000) Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 21:881–890PubMed Cha S, Knopp EA, Johnson G et al (2000) Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 21:881–890PubMed
20.
Zurück zum Zitat Bastin ME, Carpenter TK, Armitage PA, Sinha S, Wardlaw JM, Whittle IR (2006) Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 27:402–408PubMed Bastin ME, Carpenter TK, Armitage PA, Sinha S, Wardlaw JM, Whittle IR (2006) Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 27:402–408PubMed
21.
Zurück zum Zitat Ostergaard L, Hochberg FH, Rabinov JD et al (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 90:300–305PubMedCrossRef Ostergaard L, Hochberg FH, Rabinov JD et al (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 90:300–305PubMedCrossRef
22.
Zurück zum Zitat Fuss M, Wenz F, Scholdei R et al (2000) Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 48:53–58. doi:10.1016/S0360-3016(00)00590-3 PubMedCrossRef Fuss M, Wenz F, Scholdei R et al (2000) Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 48:53–58. doi:10.​1016/​S0360-3016(00)00590-3 PubMedCrossRef
26.
Zurück zum Zitat Galanis E, Buckner JC, Maurer MJ et al (2006) Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro-oncol 8:156–165. doi:10.1215/15228517-2005-005 PubMedCrossRef Galanis E, Buckner JC, Maurer MJ et al (2006) Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro-oncol 8:156–165. doi:10.​1215/​15228517-2005-005 PubMedCrossRef
27.
28.
Zurück zum Zitat Roberts HC, Roberts TP, Bollen AW, Ley S, Brasch RC, Dillon WP (2001) Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 8:384–391. doi:10.1016/S1076-6332(03)80545-7 PubMedCrossRef Roberts HC, Roberts TP, Bollen AW, Ley S, Brasch RC, Dillon WP (2001) Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 8:384–391. doi:10.​1016/​S1076-6332(03)80545-7 PubMedCrossRef
29.
Zurück zum Zitat Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479–1486PubMed Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479–1486PubMed
30.
Zurück zum Zitat Brat DJ, Castellano-Sanchez AA, Hunter SB et al (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920–927. doi:10.1158/0008-5472.CAN-03-2073 PubMedCrossRef Brat DJ, Castellano-Sanchez AA, Hunter SB et al (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920–927. doi:10.​1158/​0008-5472.​CAN-03-2073 PubMedCrossRef
33.
34.
Zurück zum Zitat Hudetz AG (2003) The cerebral microcirculation in ischemia and hypoxemia. The Arisztid G. B. Kovach Memorial Lecture. Adv Exp Med Biol 530:347–357PubMed Hudetz AG (2003) The cerebral microcirculation in ischemia and hypoxemia. The Arisztid G. B. Kovach Memorial Lecture. Adv Exp Med Biol 530:347–357PubMed
37.
38.
Zurück zum Zitat Parikh AH, Smith JK, Ewend MG, Bullitt E (2004) Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms. Technol Cancer Res Treat 3:585–590PubMed Parikh AH, Smith JK, Ewend MG, Bullitt E (2004) Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms. Technol Cancer Res Treat 3:585–590PubMed
40.
Zurück zum Zitat Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMed Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMed
Metadaten
Titel
Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma
verfasst von
Stephan Ulmer
Carsten Liess
Santosh Kesari
Nadine Otto
Torsten Straube
Olav Jansen
Publikationsdatum
01.01.2009
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2009
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-008-9701-7

Weitere Artikel der Ausgabe 2/2009

Journal of Neuro-Oncology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.